Can-Fite BioPharma (CANF) Announces Positive New Pre-Clinical Data for CF602
Tweet Send to a Friend
Can-Fite BioPharma Ltd. (NYSE: CANF) today reported new findings for its drug candidate, CF602, showing statistically significant full recovery ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
